Ruxolitinib CAS:
If you are going to consult the information about from one of the leading manufacturers and suppliers in China, Biopharmaleader Co.,Ltd is always at your service.Product InformationCAS NO. Product NameRuxolitinibSynonymsINCB018424FormulaC17H18N6Molecular Weight306.37Spec / Purity98%minSupply CapacityDetailsRuxolitinib (INC424, INCB18424) is a drug for the treatment of intermediate or high-risk myelofibrosis, a type of myeloproliferative disorder that affects the bone marrow. It is also being investigated for the treatment of other types of cancer (such as lymphomas and pancreatic cancer),[4] for polycythemia vera, for plaque psoriasis, and for alopecia areata.
Other supplier products
|
|
|
,API |
|
|
|
,Website: |
|
|
|
,Pharmaceutical Intermediate |
|
|
|
19608-29-8,Website: |
|
|
|
CAS NO.Product Name TafamidisSynonymsFx-1006A; Vyndaqel; Fx1006A; Fx 1006AFormulaC14H7Cl2NO3Molecular Weight308.12Spec / Purity98%minSupply Capaci... |
供应产品
Same products